SG11201707112PA - Anti-cancer activity of (e)-1-(3',4'-dimethoxyphenyl) butadiene - Google Patents
Anti-cancer activity of (e)-1-(3',4'-dimethoxyphenyl) butadieneInfo
- Publication number
- SG11201707112PA SG11201707112PA SG11201707112PA SG11201707112PA SG11201707112PA SG 11201707112P A SG11201707112P A SG 11201707112PA SG 11201707112P A SG11201707112P A SG 11201707112PA SG 11201707112P A SG11201707112P A SG 11201707112PA SG 11201707112P A SG11201707112P A SG 11201707112PA
- Authority
- SG
- Singapore
- Prior art keywords
- dimethoxyphenyl
- butadiene
- cancer activity
- cancer
- activity
- Prior art date
Links
- JFHQUUYHTBVHHK-AATRIKPKSA-N 4-[(1e)-buta-1,3-dienyl]-1,2-dimethoxybenzene Chemical compound COC1=CC=C(\C=C\C=C)C=C1OC JFHQUUYHTBVHHK-AATRIKPKSA-N 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662275847P | 2016-01-07 | 2016-01-07 | |
| PCT/US2016/063725 WO2017119962A1 (en) | 2016-01-07 | 2016-11-24 | Anti-cancer activity of (e)-1-(3',4'-dimethoxyphenyl) butadiene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201707112PA true SG11201707112PA (en) | 2017-09-28 |
Family
ID=59274359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201707112PA SG11201707112PA (en) | 2016-01-07 | 2016-11-24 | Anti-cancer activity of (e)-1-(3',4'-dimethoxyphenyl) butadiene |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9833422B2 (en) |
| EP (1) | EP3399987A4 (en) |
| JP (1) | JP6584526B2 (en) |
| KR (1) | KR20170134527A (en) |
| CN (1) | CN107427541A (en) |
| AU (2) | AU2016385393B2 (en) |
| CA (1) | CA2979287C (en) |
| NZ (1) | NZ735027A (en) |
| PH (1) | PH12017501663A1 (en) |
| RU (1) | RU2694053C1 (en) |
| SG (1) | SG11201707112PA (en) |
| WO (1) | WO2017119962A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050047208A (en) * | 2003-11-17 | 2005-05-20 | 학교법인 이화학당 | Composition containing the compound isolated from an extract of zingiber cassumunar for preventing and treating cancer disease |
| US20060241022A1 (en) * | 2004-10-06 | 2006-10-26 | Bowen Benjamin P | Selectin targeting bioconjugates |
| CN101175406B (en) * | 2005-03-10 | 2012-11-21 | 尤尼根公司 | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| KR101532866B1 (en) * | 2014-01-28 | 2015-06-30 | 이화여자대학교 산학협력단 | use of Zingiber cassumunar Roxb extracts or compounds isolated therefrom for enhancing melanogenesis |
| CN103784460A (en) * | 2014-02-18 | 2014-05-14 | 广州金域医学检验中心有限公司 | Combined drug for inhibiting lung carcinoma cell migration, pharmaceutical preparation and detection method |
-
2016
- 2016-11-24 CA CA2979287A patent/CA2979287C/en not_active Expired - Fee Related
- 2016-11-24 NZ NZ735027A patent/NZ735027A/en not_active IP Right Cessation
- 2016-11-24 JP JP2017553923A patent/JP6584526B2/en not_active Expired - Fee Related
- 2016-11-24 EP EP16884146.8A patent/EP3399987A4/en not_active Withdrawn
- 2016-11-24 RU RU2017133869A patent/RU2694053C1/en active
- 2016-11-24 SG SG11201707112PA patent/SG11201707112PA/en unknown
- 2016-11-24 WO PCT/US2016/063725 patent/WO2017119962A1/en active Application Filing
- 2016-11-24 KR KR1020177031023A patent/KR20170134527A/en active Search and Examination
- 2016-11-24 US US15/361,053 patent/US9833422B2/en active Active
- 2016-11-24 CN CN201680016756.2A patent/CN107427541A/en active Pending
- 2016-11-24 AU AU2016385393A patent/AU2016385393B2/en not_active Ceased
-
2017
- 2017-09-13 PH PH12017501663A patent/PH12017501663A1/en unknown
-
2018
- 2018-12-11 AU AU2018275031A patent/AU2018275031A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2979287A1 (en) | 2017-07-13 |
| KR20170134527A (en) | 2017-12-06 |
| RU2694053C1 (en) | 2019-07-09 |
| AU2016385393A1 (en) | 2017-09-21 |
| JP2018516861A (en) | 2018-06-28 |
| NZ735027A (en) | 2019-04-26 |
| US9833422B2 (en) | 2017-12-05 |
| AU2016385393B2 (en) | 2018-09-13 |
| PH12017501663A1 (en) | 2018-03-19 |
| US20170196820A1 (en) | 2017-07-13 |
| CN107427541A (en) | 2017-12-01 |
| AU2018275031A1 (en) | 2020-06-25 |
| CA2979287C (en) | 2019-12-24 |
| EP3399987A4 (en) | 2019-09-25 |
| JP6584526B2 (en) | 2019-10-02 |
| EP3399987A1 (en) | 2018-11-14 |
| WO2017119962A1 (en) | 2017-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264210A (en) | High-strength oral cannabinoid dosage forms | |
| ZA201801710B (en) | Triazole derivatives, intermediates thereof and their use as fungicides | |
| PH12017502255A1 (en) | Nrf2 regulators | |
| IL249370A0 (en) | Fap-activated therapeutic agents, and uses related thereto | |
| HK1254407A1 (en) | Ion channel inhibitory compounds, pharmaceutical formulations and uses | |
| IL272446A (en) | Substituted penta- fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof | |
| HRP20190107T1 (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| EP3259032A4 (en) | Improved descender | |
| EP3180993A4 (en) | Composition for improving skin, containing pomegranate concentrate as active ingredient | |
| AU2016361427A8 (en) | Platinum anticancer agents | |
| GB201603296D0 (en) | Chemotactic,drug-containing polymersomes | |
| WO2014152809A3 (en) | Analogs of pparo and 20-oh-pge2, and methods of using the same | |
| IL283166A (en) | Compounds that selectively and effectively inhibit hakai-mediated ubiquitination, as anti-cancer drugs | |
| ZA201800163B (en) | New anti-malarial agents | |
| EP3463579A4 (en) | Callyspongiolide, analogs thereof and uses thereof | |
| EP3542796A4 (en) | Compound having anti-cancer effect, and preparation method therefor and use thereof | |
| SG11201707112PA (en) | Anti-cancer activity of (e)-1-(3',4'-dimethoxyphenyl) butadiene | |
| HK1254516A1 (en) | Moisturizing composition containing 3-o-galloyl-3,3',5,5',7-pentahydroxyflavan | |
| IL256589A (en) | 2,4,7-trimethyloct-6-en-1-ol as fragrance ingredient | |
| EP3624809A4 (en) | Pharmaceutical agents, compositions, and methods relating thereto | |
| EP3280261A4 (en) | Anticancer therapeutic agents | |
| GB201714446D0 (en) | Drug intermediates 3,4,5-trimethoxybenzaldehyde synthesis method | |
| EP3458439A4 (en) | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use | |
| GB201523232D0 (en) | Farrerol drug intermediates 2,6-dimethyl-acetanillide synthesis method | |
| GB201614847D0 (en) | Dextranase medicament |